Earlier this week, Tris Pharma—a major pharmaceutical company based in New Jersey— issued a voluntary nationwide recall of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) due to potential higher concentrations of ibuprofen.
The products were labeled as 50 mg of ibuprofen per 1.25 mL, however, the company claims the concentration may be higher than labeled. There’s a remote possibility that the higher dosage in these products could lead to permanent kidney injury, nausea, and vomiting among other adverse effects. To date, the company says it has not received any reports of harmful events related to the recall.
The products in question were sold at Walmart, CVS and Family Dollar under the brand names Equate, CVS Health and Family Wellness. Infants’ ibuprofen is often recommended by health care professionals as a pain reliever and fever reducer for infants.
(Photos: PRNewsfoto/Tris Phara Inc.)
Tris Pharma has issued an urgent recall notice and wholesalers and retailers have been instructed to stop further distribution of the affected lots of ibuprofen.
More information about the recall is available from the company’s official release.
If you have any health-related questions or concerns about this recall please call us at 970-267-9510.